These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 17035661)

  • 1. Long-term raloxifene in a woman at high risk for breast cancer.
    Bean GR; Kimler BF; Seewaldt VL
    N Engl J Med; 2006 Oct; 355(15):1620-2. PubMed ID: 17035661
    [No Abstract]   [Full Text] [Related]  

  • 2. Experts hopeful about designer estrogens. For some women, selective estrogen receptor modulators (SERMs) help prevent breast cancer.
    Runowicz CD
    Health News; 2003 Apr; 9(4):1-2. PubMed ID: 12710388
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of breast cancer using selective oestrogen receptor modulators (SERMs).
    Powles TJ
    Breast Cancer Res; 2006; 8(5):111. PubMed ID: 17049068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raloxifene for the treatment and prevention of breast cancer?
    Pappas SG; Jordan VC
    Expert Rev Anticancer Ther; 2001 Oct; 1(3):334-40. PubMed ID: 12113100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The STAR trial: evidence for raloxifene as a breast cancer risk reduction agent for postmenopausal women.
    Bevers TB
    J Natl Compr Canc Netw; 2007 Sep; 5(8):719-24. PubMed ID: 17927929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raloxifene (Evista) for breast cancer prevention in postmenopausal women.
    Med Lett Drugs Ther; 2006 May; 48(1234):37. PubMed ID: 16685245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is raloxifene ready to be used for prevention of breast cancer?
    Powles TJ
    Int J Fertil Womens Med; 2006; 51(5):203-4. PubMed ID: 17269585
    [No Abstract]   [Full Text] [Related]  

  • 8. Risks, benefits, and effects on quality of life of selective estrogen-receptor modulator therapy in postmenopausal women at increased risk of breast cancer.
    Ganz PA; Land SR
    Menopause; 2008; 15(4 Suppl):797-803. PubMed ID: 18596601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raloxifene works as well as tamoxifen in preventing invasive breast cancer.
    Mayo Clin Womens Healthsource; 2006 Oct; 10(10):3. PubMed ID: 16977270
    [No Abstract]   [Full Text] [Related]  

  • 10. [Role of estrogen and selective estrogen receptor modulators in anti-aging].
    Ohta H
    Clin Calcium; 2008 Jul; 18(7):986-94. PubMed ID: 18591752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprevention of breast cancer: recommendations and rationale.
    Berg AO;
    Am J Nurs; 2003 May; 103(5):107, 109, 111, 113. PubMed ID: 12759615
    [No Abstract]   [Full Text] [Related]  

  • 12. Drugs can reduce the incidence of breast cancer: now what?
    Wozniak TF; Eppes PG; Wilson CT
    Del Med J; 1999 Sep; 71(9):387-9. PubMed ID: 10584440
    [No Abstract]   [Full Text] [Related]  

  • 13. Tamoxifen, raloxifene and the prevention of breast cancer.
    Bentrem DJ; Craig Jordan V
    Minerva Endocrinol; 2002 Jun; 27(2):127-39. PubMed ID: 11961504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining the role of raloxifene for the prevention of breast cancer.
    Kalidas M; Hilsenbeck S; Brown P
    J Natl Cancer Inst; 2004 Dec; 96(23):1731-3. PubMed ID: 15572750
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of SERM on breast cancer and cardiovascular disease: making a comparison between raloxifene use and hormone replacement therapy on the risks of the diseases].
    Higuchi T; Mizunuma H
    Clin Calcium; 2004 Oct; 14(10):81-4. PubMed ID: 15577136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical experience with raloxifene].
    Szúcs J; Pávó I; Jurida N
    Orv Hetil; 2000 Jan; 141(5):237-40. PubMed ID: 10697982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A reconsideration of tamoxifen use for breast cancer.
    Wang PH; Chao HT
    Taiwan J Obstet Gynecol; 2007 Jun; 46(2):93-5. PubMed ID: 17638615
    [No Abstract]   [Full Text] [Related]  

  • 18. [Which is the better choice, estrogen or SERMs in postmenopausal women?].
    Shintani M
    Clin Calcium; 2004 Oct; 14(10):105-10. PubMed ID: 15577140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of SERMs on bone health. Raloxifene effects on breast cancer and cardiovascular events].
    Inoue D
    Clin Calcium; 2010 Mar; 20(3):331-8. PubMed ID: 20190362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reaping the benefits of designer estrogens.
    Johns Hopkins Med Lett Health After 50; 1999 Nov; 11(9):6-7. PubMed ID: 10530089
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.